Evidence map›Paper›PMID 29438273›Full record

ArticleToxins2018

Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication.

Adva Mechaly, Ron Alcalay, Tal Noy-Porat, Eyal Epstein, Yoav Gal, Ohad Mazor

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mapping Immunodominant Antibody Epitopes of Abrin.Antibodies (Basel, Switzerland) · 2020
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Adva MechalyDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona 76100, Israel. advam@iibr.gov.il.
Ron AlcalayDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 76100, Israel. rona@iibr.gov.il.
Tal Noy-PoratDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 76100, Israel.
Eyal EpsteinDepartment of Biotechnology, Israel Institute for Biological Research, Ness-Ziona 76100, Israel. eyale@iibr.gov.il.
Yoav GalDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 76100, Israel. yoavg@iibr.gov.il.
Ohad MazorDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona 76100, Israel. ohadm@iibr.gov.il.
Israel Institute for Biological Research · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abrin toxin is a type 2 ribosome inactivating glycoprotein isolated from the seeds of

Indexed as

AbrinAnimalsCell Surface Display TechniquesFemaleHeLa CellsHumansImmunizationMice, Inbred ICRNeutralization TestsRabbitsSingle-Chain AntibodiesAbrinSingle-Chain Antibodiesabrinmonoclonal antibodiesphage-displayrabbitrecombinant antibodies

Identifiers

PMID29438273
PMCPMC5848181
OpenAlexW2790551721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.